United States Central Nervous System Biomarkers Market Report 2017

United States Central Nervous System Biomarkers Market Report 2017

1 Central Nervous System Biomarkers Overview

1.1 Product Overview and Scope of Central Nervous System Biomarkers

1.2 Classification of Central Nervous System Biomarkers by Product Category

1.2.1 United States Central Nervous System Biomarkers Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Central Nervous System Biomarkers Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Safety Biomarker

1.2.4 Efficacy Biomarker

1.2.5 Validation Biomarker

1.2.6 Other

1.3 United States Central Nervous System Biomarkers Market by Application/End Users

1.3.1 United States Central Nervous System Biomarkers Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 United States Central Nervous System Biomarkers Market by Region

1.4.1 United States Central Nervous System Biomarkers Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Central Nervous System Biomarkers Status and Prospect (2012-2022)

1.4.3 Southwest Central Nervous System Biomarkers Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Central Nervous System Biomarkers Status and Prospect (2012-2022)

1.4.5 New England Central Nervous System Biomarkers Status and Prospect (2012-2022)

1.4.6 The South Central Nervous System Biomarkers Status and Prospect (2012-2022)

1.4.7 The Midwest Central Nervous System Biomarkers Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Central Nervous System Biomarkers (2012-2022)

1.5.1 United States Central Nervous System Biomarkers Sales and Growth Rate (2012-2022)

1.5.2 United States Central Nervous System Biomarkers Revenue and Growth Rate (2012-2022)

2 United States Central Nervous System Biomarkers Market Competition by Players/Suppliers

2.1 United States Central Nervous System Biomarkers Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Central Nervous System Biomarkers Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Central Nervous System Biomarkers Average Price by Players/Suppliers (2012-2017)

2.4 United States Central Nervous System Biomarkers Market Competitive Situation and Trends

2.4.1 United States Central Nervous System Biomarkers Market Concentration Rate

2.4.2 United States Central Nervous System Biomarkers Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Central Nervous System Biomarkers Manufacturing Base Distribution, Sales Area, Product Type

3 United States Central Nervous System Biomarkers Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Central Nervous System Biomarkers Sales and Market Share by Region (2012-2017)

3.2 United States Central Nervous System Biomarkers Revenue and Market Share by Region (2012-2017)

3.3 United States Central Nervous System Biomarkers Price by Region (2012-2017)

4 United States Central Nervous System Biomarkers Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Central Nervous System Biomarkers Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Central Nervous System Biomarkers Revenue and Market Share by Type (2012-2017)

4.3 United States Central Nervous System Biomarkers Price by Type (2012-2017)

4.4 United States Central Nervous System Biomarkers Sales Growth Rate by Type (2012-2017)

5 United States Central Nervous System Biomarkers Sales (Volume) by Application (2012-2017)

5.1 United States Central Nervous System Biomarkers Sales and Market Share by Application (2012-2017)

5.2 United States Central Nervous System Biomarkers Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Central Nervous System Biomarkers Players/Suppliers Profiles and Sales Data

6.1 Thermo Fisher Scientific

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Central Nervous System Biomarkers Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Thermo Fisher Scientific Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Merck & Co

6.2.2 Central Nervous System Biomarkers Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Merck & Co Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 AbaStar MDx Inc

6.3.2 Central Nervous System Biomarkers Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 AbaStar MDx Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Abiant, Inc

6.4.2 Central Nervous System Biomarkers Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Abiant, Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Avacta Group Plc

6.5.2 Central Nervous System Biomarkers Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Avacta Group Plc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Diagenic Asa

6.6.2 Central Nervous System Biomarkers Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Diagenic Asa Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Banyan Biomarkers

6.7.2 Central Nervous System Biomarkers Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Banyan Biomarkers Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Avid Radiopharmaceuticals Inc

6.8.2 Central Nervous System Biomarkers Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

7 Central Nervous System Biomarkers Manufacturing Cost Analysis

7.1 Central Nervous System Biomarkers Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Central Nervous System Biomarkers

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Central Nervous System Biomarkers Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Central Nervous System Biomarkers Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Central Nervous System Biomarkers Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Central Nervous System Biomarkers Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Central Nervous System Biomarkers Sales Volume Forecast by Type (2017-2022)

11.3 United States Central Nervous System Biomarkers Sales Volume Forecast by Application (2017-2022)

11.4 United States Central Nervous System Biomarkers Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Central Nervous System Biomarkers

Figure United States Central Nervous System Biomarkers Market Size (K Units) by Type (2012-2022)

Figure United States Central Nervous System Biomarkers Sales Volume Market Share by Type (Product Category) in 2016

Figure Safety Biomarker Product Picture

Figure Efficacy Biomarker Product Picture

Figure Validation Biomarker Product Picture

Figure Other Product Picture

Figure United States Central Nervous System Biomarkers Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Central Nervous System Biomarkers by Application in 2016

Figure Hospitals Examples

Table Key Downstream Customer in Hospitals

Figure Clinics Examples

Table Key Downstream Customer in Clinics

Figure Other Examples

Table Key Downstream Customer in Other

Figure United States Central Nervous System Biomarkers Market Size (Million USD) by Region (2012-2022)

Figure The West Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Central Nervous System Biomarkers Sales (K Units) and Growth Rate (2012-2022)

Figure United States Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Central Nervous System Biomarkers Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Central Nervous System Biomarkers Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Central Nervous System Biomarkers Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Central Nervous System Biomarkers Sales Share by Players/Suppliers

Figure 2017 United States Central Nervous System Biomarkers Sales Share by Players/Suppliers

Figure United States Central Nervous System Biomarkers Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Central Nervous System Biomarkers Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Central Nervous System Biomarkers Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Central Nervous System Biomarkers Revenue Share by Players/Suppliers

Figure 2017 United States Central Nervous System Biomarkers Revenue Share by Players/Suppliers

Table United States Market Central Nervous System Biomarkers Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Central Nervous System Biomarkers Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Central Nervous System Biomarkers Market Share of Top 3 Players/Suppliers

Figure United States Central Nervous System Biomarkers Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Central Nervous System Biomarkers Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Central Nervous System Biomarkers Product Category

Table United States Central Nervous System Biomarkers Sales (K Units) by Region (2012-2017)

Table United States Central Nervous System Biomarkers Sales Share by Region (2012-2017)

Figure United States Central Nervous System Biomarkers Sales Share by Region (2012-2017)

Figure United States Central Nervous System Biomarkers Sales Market Share by Region in 2016

Table United States Central Nervous System Biomarkers Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Central Nervous System Biomarkers Revenue Share by Region (2012-2017)

Figure United States Central Nervous System Biomarkers Revenue Market Share by Region (2012-2017)

Figure United States Central Nervous System Biomarkers Revenue Market Share by Region in 2016

Table United States Central Nervous System Biomarkers Price (USD/Unit) by Region (2012-2017)

Table United States Central Nervous System Biomarkers Sales (K Units) by Type (2012-2017)

Table United States Central Nervous System Biomarkers Sales Share by Type (2012-2017)

Figure United States Central Nervous System Biomarkers Sales Share by Type (2012-2017)

Figure United States Central Nervous System Biomarkers Sales Market Share by Type in 2016

Table United States Central Nervous System Biomarkers Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Central Nervous System Biomarkers Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Central Nervous System Biomarkers by Type (2012-2017)

Figure Revenue Market Share of Central Nervous System Biomarkers by Type in 2016

Table United States Central Nervous System Biomarkers Price (USD/Unit) by Types (2012-2017)

Figure United States Central Nervous System Biomarkers Sales Growth Rate by Type (2012-2017)

Table United States Central Nervous System Biomarkers Sales (K Units) by Application (2012-2017)

Table United States Central Nervous System Biomarkers Sales Market Share by Application (2012-2017)

Figure United States Central Nervous System Biomarkers Sales Market Share by Application (2012-2017)

Figure United States Central Nervous System Biomarkers Sales Market Share by Application in 2016

Table United States Central Nervous System Biomarkers Sales Growth Rate by Application (2012-2017)

Figure United States Central Nervous System Biomarkers Sales Growth Rate by Application (2012-2017)

Table Thermo Fisher Scientific Basic Information List

Table Thermo Fisher Scientific Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Thermo Fisher Scientific Central Nervous System Biomarkers Sales Growth Rate (2012-2017)

Figure Thermo Fisher Scientific Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)

Figure Thermo Fisher Scientific Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)

Table Merck & Co Basic Information List

Table Merck & Co Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Merck & Co Central Nervous System Biomarkers Sales Growth Rate (2012-2017)

Figure Merck & Co Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)

Figure Merck & Co Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)

Table AbaStar MDx Inc Basic Information List

Table AbaStar MDx Inc Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure AbaStar MDx Inc Central Nervous System Biomarkers Sales Growth Rate (2012-2017)

Figure AbaStar MDx Inc Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)

Figure AbaStar MDx Inc Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)

Table Abiant, Inc Basic Information List

Table Abiant, Inc Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Abiant, Inc Central Nervous System Biomarkers Sales Growth Rate (2012-2017)

Figure Abiant, Inc Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)

Figure Abiant, Inc Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)

Table Avacta Group Plc Basic Information List

Table Avacta Group Plc Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Avacta Group Plc Central Nervous System Biomarkers Sales Growth Rate (2012-2017)

Figure Avacta Group Plc Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)

Figure Avacta Group Plc Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)

Table Diagenic Asa Basic Information List

Table Diagenic Asa Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Diagenic Asa Central Nervous System Biomarkers Sales Growth Rate (2012-2017)

Figure Diagenic Asa Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)

Figure Diagenic Asa Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)

Table Banyan Biomarkers Basic Information List

Table Banyan Biomarkers Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Banyan Biomarkers Central Nervous System Biomarkers Sales Growth Rate (2012-2017)

Figure Banyan Biomarkers Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)

Figure Banyan Biomarkers Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)

Table Avid Radiopharmaceuticals Inc Basic Information List

Table Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Sales Growth Rate (2012-2017)

Figure Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Sales Market Share in United States (2012-2017)

Figure Avid Radiopharmaceuticals Inc Central Nervous System Biomarkers Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Central Nervous System Biomarkers

Figure Manufacturing Process Analysis of Central Nervous System Biomarkers

Figure Central Nervous System Biomarkers Industrial Chain Analysis

Table Raw Materials Sources of Central Nervous System Biomarkers Major Players/Suppliers in 2016

Table Major Buyers of Central Nervous System Biomarkers

Table Distributors/Traders List

Figure United States Central Nervous System Biomarkers Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Central Nervous System Biomarkers Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Central Nervous System Biomarkers Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Type in 2022

Table United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Application in 2022

Table United States Central Nervous System Biomarkers Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Central Nervous System Biomarkers Sales Volume Share Forecast by Region (2017-2022)

Figure United States Central Nervous System Biomarkers Sales Volume Share Forecast by Region (2017-2022)

Figure United States Central Nervous System Biomarkers Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources